Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib in Depression and Cognition in Male Football Players
NCT07608796Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib in major depressive disorder (MDD), cognitive dysfunction, sponsored by Emory University. Started Oct 2026; status: recruiting.
02
Drugs
baricitinib
03
Conditions
major depressive disorder (MDD)cognitive dysfunction
Beyond the preview
Go deeper on NCT07608796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07608796.